Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mahar

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Respirology (Carlton, Vic.)|July 19, 2016
Clinical impact of the interstitial lung disease multidisciplinary serviceHelen E Jo, Ian N Glaspole, Kovi C Levin, et al.
Respirology (Carlton, Vic.)|January 8, 2026
Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary FibrosisJohn A Mackintosh, Simon L F Walsh, Mario Silva, et al.
The European Respiratory Journal|May 9, 2020
Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosisBritt Clynick, Helen E Jo, Tamera J Corte, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed TomographySimon L F Walsh, John A Mackintosh, Lucio Calandriello, et al.
Respirology (Carlton, Vic.)|October 18, 2018
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Nicole Goh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2024
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working GroupHelen E Rollison, Pallabi Mitra, Hugues Chanteux, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2026
Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical DevelopmentRucha S Sane, Pallabi Mitra, Yurong Lai, et al.
The European Respiratory Journal|October 22, 2021
Biomarker signatures for progressive idiopathic pulmonary fibrosisBritt Clynick, Tamera J Corte, Helen E Jo, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Respirology (Carlton, Vic.)|July 19, 2016
Clinical impact of the interstitial lung disease multidisciplinary serviceHelen E Jo, Ian N Glaspole, Kovi C Levin, et al.
Respirology (Carlton, Vic.)|January 8, 2026
Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary FibrosisJohn A Mackintosh, Simon L F Walsh, Mario Silva, et al.
The European Respiratory Journal|May 9, 2020
Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosisBritt Clynick, Helen E Jo, Tamera J Corte, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed TomographySimon L F Walsh, John A Mackintosh, Lucio Calandriello, et al.
Respirology (Carlton, Vic.)|October 18, 2018
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Nicole Goh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2024
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working GroupHelen E Rollison, Pallabi Mitra, Hugues Chanteux, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2026
Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical DevelopmentRucha S Sane, Pallabi Mitra, Yurong Lai, et al.
The European Respiratory Journal|October 22, 2021
Biomarker signatures for progressive idiopathic pulmonary fibrosisBritt Clynick, Tamera J Corte, Helen E Jo, et al.
Pageof 5